ESC Premium Access

Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia

Topic: Primary cardiovascular prevention: interventions and outcomes

Congress Presentation

About the speaker

Doctor G Kees Hovingh

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
1 presentation
0 follower

19 more presentations in this session

Nurse-led telephone-based follow-up of secondary prevention after acute myocardial infarction: one-year results from the randomized controlled NAILED-ACS trial.

Speaker: Doctor D. Huber (Umea, SE)

Thumbnail

Six sigma approach to reduce door-to-balloon time for patients with ST-elevation myocardial infarction undergoing primary PCI

Speaker: Doctor T. Sharma (Baltimore, US)

Thumbnail

Evolution of European Society of Cardiology Guidelines since 2000: a systematic appraisal

Speaker: Doctor C. Badu-Boateng (Surrey, GB)

Thumbnail

Inhibition of acetylcholinesterase by bromide pyridostigmine prevents ventricular dysfunction, autonomic and reduce inflammatory profile in rats treated previously to myocardial infarction

Speaker: Ms C. Barboza (Sao Paulo, BR)

Thumbnail

Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor D. Brie (Timisoara, RO)

Thumbnail

Access the full session

Poster session 2 - Cardiovascular prevention outcomes I

Speakers: Doctor G. Hovingh, Doctor D. Huber, Doctor T. Sharma, Doctor C. Badu-Boateng, Ms C. Barboza...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk